Receptor-independent actions of PPAR thiazolidinedione agonists: Is mitochondrial function the key?
Feinstein, D.L., Spagnolo, A., Akar, C., Weinberg, G., Murphy, P., Gavrilyuk, V., Russo, C. Dello·2005·Biochemical Pharmacology
Cited by (278)
Items 101–200 of 278
- Rosiglitazone promotes neurite outgrowth and mitochondrial function in N2A cells via PPARgamma pathwayMing‐Chang Chiang, Yi‐Chuan Cheng, Han‐Min Chen, Yao‐Jen Liang, Chia-Hui Yen · 2013 · Mitochondrion
- Deuterium‐Stabilized (R)‐Pioglitazone (PXL065) Is Responsible for Pioglitazone Efficacy in NASH yet Exhibits Little to No PPARγ ActivityVincent Jacques, Sébastien Bolze, Sophie Hallakou‐Bozec, Anthony W. Czarnik, Ajit S. Divakaruni, Pascale Fouqueray, Anne N. Murphy, Lex H.T. Van der Ploeg, Sheila Hobbs DeWitt · 2021 · Hepatology Communications
- Cyclooxygenase (COX) Inhibitors and the IntestineDianne Little, Samuel L. Jones, Anthony T. Blikslager · 2007 · Journal of Veterinary Internal Medicine
- Nutrient-Deprivation Autophagy Factor-1 (NAF-1): Biochemical Properties of a Novel Cellular Target for Anti-Diabetic DrugsSagi Tamir, John A. Zuris, Lily Agranat-Tamir, Colin H. Lipper, Andrea R. Conlan, Dorit Michaeli, Yael Harir, Mark L. Paddock, Ron Mittler, Zvi Ioav Cabantchik et al. · 2013 · PLoS ONE
- The potential of antidiabetic thiazolidinediones for anticancer therapyAndrea Galli, Tommaso Mello, Elisabetta Ceni, Elisabetta Surrenti, C. Surrenti · 2006 · Expert Opinion on Investigational Drugs
- Mitochondrial dysfunction and delayed hepatotoxicity: another lesson from troglitazoneNeil L. Julie, I. M. Julie, A. I. Kende, G. Lee Wilson · 2008 · Diabetologia
- Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 DiabetesRyan B. Griggs, Renée R. Donahue, Braxton G. Adkins, Katie L. Anderson, Olivier Thibault, Bradley Kenneth Taylor · 2015 · Journal of Pain
- Glitazones Induce Astroglioma Cell Death by Releasing Reactive Oxygen Species from Mitochondria: Modulation of Cytotoxicity by Nitric OxideJosé Manuel Pérez‐Ortiz, Pedro Tranque, Miguel Burgos, Cecilia F. Vaquero, Juan L. Llopis · 2007 · Molecular Pharmacology
- The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cellsKUN-HUANG YAN, Chih‐Jung Yao, Hwan‐You Chang, Gi‐Ming Lai, Ann‐Lii Cheng, Shuang‐En Chuang · 2009 · Molecular Carcinogenesis
- New Mechanism of Rosiglitazone to Reduce Neointimal HyperplasiaChoon-Soo Lee, Yoo‐Wook Kwon, Han‐Mo Yang, Sung Hwan Kim, Tae-Youn Kim, Jin Hur, Kyung Woo Park, Hyun-Jai Cho, Hyun‐Jae Kang, Young-Bae Park et al. · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
- Activation of Peroxisome Proliferator-Activated Receptor-γ Decreases Pancreatic Cancer Cell Invasion through Modulation of the Plasminogen Activator SystemHirozumi Sawai, Joey Liu, Howard A. Reber, Oscar Joe Hines, Guido Eibl · 2006 · Molecular Cancer Research
- Peroxisome Proliferator-Activated Receptor γ Agonists Accelerate Oligodendrocyte Maturation and Influence Mitochondrial Functions and Oscillatory Ca2+WavesChiara De Nuccio, Antonietta Bernardo, Roberta De Simone, Enrico Mancuso, Valerio Magnaghi, Sergio Visentin, Luisa Minghetti · 2011 · Journal of Neuropathology & Experimental Neurology
- An Insulin-Sensitizing Thiazolidinedione, Which Minimally Activates PPARγ, Does Not Cause Bone LossTomohiro Fukunaga, Wei Zou, Nidhi Rohatgi, Jerry R. Colca, Steven L. Teitelbaum · 2014 · Journal of Bone and Mineral Research
- Troglitazone, a peroxisome proliferator‐activated receptor‐γ agonist, decreases tau phosphorylation in CHOtau4R cellsCristina d’Abramo, Roberta Ricciarelli, Maria Adelaide Pronzato, Peter Davies · 2006 · Journal of Neurochemistry
- A Novel MitoNEET Ligand, TT01001, Improves Diabetes and Ameliorates Mitochondrial Function in db/db MiceTakehiro Takahashi, Masashi Yamamoto, Kazutoshi Amikura, Kozue Kato, Takashi Serizawa, Kanako Serizawa, Daisuke Akazawa, Takumi Aoki, Koji Kawai, Emi Ogasawara et al. · 2014 · Journal of Pharmacology and Experimental Therapeutics
- PPAR-γ activation enhances myelination and neurological recovery in premature rabbits with intraventricular hemorrhageSunil Krishna, Bokun Cheng, Deep Raj Sharma, Sunita Yadav, Erin Stempinski, Sahil S Mamtani, Elisa Shah, Anjali Deo, Trishna Acherjee, Teena Thomas et al. · 2021 · Proceedings of the National Academy of Sciences
- Mitochondria, PPARs, and Cancer: Is Receptor‐Independent Action of PPAR Agonists a Key?Roberto Scatena, Patrizia Bottoni, Bruno Giardina · 2008 · PPAR Research
- Rosiglitazone Affects Nitric Oxide Synthases and Improves Renal Outcome in a Rat Model of Severe Ischemia/Reperfusion InjuryBoris B. Betz, Reinhard Schneider, Tobias Kress, Martin Alexander Schick, Christoph Wanner, Christoph Sauvant · 2012 · PPAR Research
- Rosiglitazone reduces tau phosphorylation via JNK inhibition in the hippocampus of rats with type 2 diabetes and tau transfected SH-SY5Y cellsSeung‐Yong Yoon, Jeong-Su Park, Jung‐Eun Choi, Jin-Myung Choi, Woo-Je Lee, Seong-Who Kim, Dong‐Hou Kim · 2010 · Neurobiology of Disease
- Glutaminolysis and glycolysis regulation by troglitazone in breast cancer cells: Relationship to mitochondrial membrane potentialEllen Friday, Robert Oliver, Tomas Welbourne, Francesco Turturro · 2010 · Journal of Cellular Physiology
- Chemical Proteomics-Based Analysis of Off-Target Binding Profiles for Rosiglitazone and Pioglitazone: Clues for Assessing Potential for CardiotoxicityBrian Robert Hoffmann, Mohamed F. El‐Mansy, Daniel S. Sem, Andrew Seth Greene · 2012 · Journal of Medicinal Chemistry
- Mood, Memory and Movement: An Age-Related Neurodegenerative Complex?Ann‐Charlotte Granholm, Heather A. Boger, Marina Elena Emborg · 2008 · Current Aging Science
- Thiazolidinediones induce proliferation of human bronchial epithelial cells through the GPR40 receptorDelphine Gras, Pascal Chanez, Valérie Urbach, Isabelle Vachier, Philippe Godard, Caroline Bonnans · 2009 · American Journal of Physiology-Lung Cellular and Molecular Physiology
- Heme oxygenase-1 induction by rosiglitazone via PKCα/AMPKα/p38 MAPKα/SIRT1/PPARγ pathway suppresses lipopolysaccharide-mediated pulmonary inflammationRou‐Ling Cho, Wei‐Ning Lin, Chen-Yu Wang, Chien-Chung Yang, Li‐Der Hsiao, Chih‐Chung Lin, Chuen‐Mao Yang · 2018 · Biochemical Pharmacology
- Insulin Sensitizing Pharmacology of Thiazolidinediones Correlates with Mitochondrial Gene Expression rather than Activation of PPARγCharles W. Bolten, Patrick M. Blanner, William G. McDonald, Nicholas R. Staten, Richard A. Mazzarella, Graciela B. Arhancet, Martin F. Meier, David J. Weiss, Patrick M. Sullivan, Alexander E. Hromockyj et al. · 2007 · Gene Regulation and Systems Biology
- Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated miceDaniele Lecca, Daniel K. Nevin, Giovanna Mulas, M.A. Casu, Andrea Diana, D. Rossi, G. Sacchetti, Anna Rosa Carta · 2015 · Neuroscience
- Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin FibrosisBenjamin D. Korman, Roberta Gonçalves Marangoni, Gabriel Lord, Jerrold M. Olefsky, Warren G. Tourtellotte, John Varga · 2018 · Arthritis Research & Therapy
- Chemical Tools for Targeted Amplification of Reactive Oxygen Species in NeutrophilsViktor Reshetnikov, Jonas Hahn, Christian Maueröder, Christine Czegley, Luis Enrique Munoz, Martin Herrmann i, Markus H. Hoffmann, Andriy A. Mokhir · 2018 · Frontiers in Immunology
- What has prevented the expansion of insulin sensitisers?Jerry R. Colca, Rolf F. Kletzien · 2006 · Expert Opinion on Investigational Drugs
- Rosiglitazone Increases the Expression of Peroxisome Proliferator-Activated Receptor-γ Target Genes in Adipose Tissue, Liver, and Skeletal Muscle in the Sheep Fetus in Late GestationBeverly Sara Mühlhäusler, Janna Leigh Morrison, I. Caroline McMillen · 2009 · Endocrinology
- Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate MetabolismMcCommis, Kyle S., Finck, Brian N. · 2019 · Cellular and Molecular Gastroenterology and Hepatology
- Pioglitazone inhibits mitochondrial pyruvate metabolism and glucose production in hepatocytesChris E. Shannon, Giuseppe Daniele, Cynthia Galindo, Muhammad A. Abdul-Ghani, Ralph A. DeFronzo, Luke Norton · 2016 · FEBS Journal
- Novel ligands that target the mitochondrial membrane protein mitoNEETRobert M. Bieganski, Martin L. Yarmush · 2011 · Journal of Molecular Graphics and Modelling
- Administration of thiazolidinediones for neuroprotection in ischemic stroke: a pre‐clinical systematic reviewAmanda T. White, Anne N. Murphy · 2010 · Journal of Neurochemistry
- The TZD insulin sensitizer clue provides a new route into diabetes drug discoveryJerry R. Colca · 2015 · Expert Opinion on Drug Discovery
- Rosiglitazone enhances learning, place cell activity, and synaptic plasticity in middle-aged ratsBoon Wan Wang, Vincent Hok, Andrea Della-Chiesa, Charlotte K. Callaghan, Sally H. Barlow, Marian Tsanov, Ranya G. Bechara, Elaine A Irving, David J. Virley, Neil Upton et al. · 2011 · Neurobiology of Aging
- BNIP3 is essential for mitochondrial bioenergetics during adipocyte remodelling in miceJin Woo Choi, Anna Jo, Min Kim, Ho Seon Park, Sung Soo Chung, Shinae Kang, Kyong Soo Park · 2015 · Diabetologia
- Troglitazone and pioglitazone interactions via PPAR-γ-independent and -dependent pathways in regulating physiological responses in renal tubule-derived cell linesFrancesco Turturro, Robert Oliver, Ellen Friday, Itzhak Nissim, Tomas Welbourne · 2006 · American Journal of Physiology-Cell Physiology
- Rosiglitazone Prevents Amyloid-β Oligomer-Induced Impairment of Synapse Formation and Plasticity via Increasing Dendrite and Spine Mitochondrial NumberShujun Xu, Liu Guilan, Xiaoming Bao, Jie Wu, Shaomin Li, Bangxu Zheng, Roger Anwyl, Qinwen Wang · 2014 · Journal of Alzheimer s Disease
- Neuroprotective mechanisms of peroxisome proliferator-activated receptor agonists in Alzheimer’s diseaseRupinder Kaur Sodhi, Nirmal Singh, Amteshwar Singh Jaggi · 2011 · Naunyn-Schmiedeberg s Archives of Pharmacology
- 15‐Deoxy‐Δ12,14‐prostaglandin J2 (15d‐ PGJ 2) protects neurons from oxidative death via an Nrf2 astrocyte‐specific mechanism independent of PPAR γRenée E. Haskew-Layton, Jimmy B. Payappilly, Hongbin Xu, Steffany A. L. Bennett, Rajiv R. Ratan · 2012 · Journal of Neurochemistry
- PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR γ‐INDEPENDENT EFFECTS OF THIAZOLIDINEDIONES ON HUMAN CARDIAC MYOFIBROBLAST FUNCTIONRomana S. Mughal, Philip Warburton, David John O'Regan, Stephen G. Ball, Neil A. Turner, Karen E. Porter · 2008 · Clinical and Experimental Pharmacology and Physiology
- Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin‐dependent kinase 5 activity in SH‐SY5Y neuroblastoma cells and primary neuronsDu‐Hyong Cho, Eun Joo Lee, Kyoung Ja Kwon, Chan Young Shin, Kee‐Ho Song, Jung‐Hyun Park, Inho Jo, Seol‐Heui Han · 2013 · Journal of Neurochemistry
- Acute Mitochondrial Actions of Glitazones on the Liver: a Crucial Parameter for their Antidiabetic PropertiesMaría-Nieves Sanz, Carlos Sànchez‐Martìn, Dominique Détaille, Guillaume Vial, Michel Rigoulet, Mohammed-Yehia El-Mir, Gloria R. Villanueva · 2011 · Cellular Physiology and Biochemistry
- Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea‐predominant irritable bowel syndrome: Role of nitric oxidePedram Paragomi, Reza Rahimian, Mohammad Hossein Kazemi, Mohammad Hadi Gharedaghi, Amin Khalifeh‐Soltani, Saeedeh Azary, Abbas Norouzi‐Javidan, Kamran Moradi, Stephen Sakuma, Ahmad Reza Dehpour · 2013 · Clinical and Experimental Pharmacology and Physiology
- The Role of PPAR‐γ and Its Interaction with COX‐2 in Pancreatic CancerGuido Eibl · 2008 · PPAR Research
- Drug-induced mitochondrial dysfunction in cardiac and skeletal muscle injuryVilma A. Sardão, Sandro L. Pereira, Paulo Jorge Oliveira · 2008 · Expert Opinion on Drug Safety
- 15‐deoxy‐Δ12,14‐prostaglandin J2 (15d‐PGJ2) and ciglitazone modulate Staphylococcus aureus‐dependent astrocyte activation primarily through a PPAR‐γ‐independent pathwayNirmal K. Phulwani, Douglas L. Feinstein, Vitaliy Gavrilyuk, Candan A Akar, Tammy Kielian · 2006 · Journal of Neurochemistry
- Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?McIntyre, Roger S, Soczynska, Joanna K, Woldeyohannes, Hanna O, Lewis, Gary F, Leiter, Lawrence A, MacQueen, Glenda M, Miranda, Andrew, Fulgosi, Don, Konarski, Jakub Z, Kennedy, Sidney H · 2007 · Expert Opinion on Pharmacotherapy
- A rapid, PPAR-γ-dependent effect of pioglitazone on the phosphorylation of MYPTKevin Brady Atkins, Brittany Irey, Nan Xiang, Frank Chip Brosius · 2009 · American Journal of Physiology-Cell Physiology
- Curcumin protects neurons against oxygen‐glucose deprivation/reoxygenation‐induced injury through activation of peroxisome proliferator‐activated receptor‐γ functionZunjing Liu, Hong‐Qiang Liu, Cheng Xiao, Hui‐Zhen Fan, Qing Huang, Yun‐Hai Liu, Yu Wang · 2014 · Journal of Neuroscience Research
- Tesaglitazar, a PPARα/γ Agonist, Induces Interstitial Mesenchymal Cell DNA Synthesis and Fibrosarcomas in Subcutaneous Tissues in RatsHeike Hellmold, Hui Zhang, Ulf Andersson, Bo Blomgren, Tom Holland, Anna‐Lena Berg, Marie Elebring, Niclas Sjögren, Krister Bamberg, Björn Dahl et al. · 2007 · Toxicological Sciences
- Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant systemUdayakumar Karunakaran, Suma Elumalai, Jun Sung Moon, Kyu Chang Won · 2021 · Redox Biology
- Mitochondrial target of thiazolidinedionesJerry R. Colca, W. G. McDonald, Rolf F. Kletzien · 2014 · Diabetes Obesity and Metabolism
- CISD2 plays a role in age-related diseases and cancerHai-Yang Liao, Bei Liao, Haihong Zhang · 2021 · Biomedicine & Pharmacotherapy
- Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesisCostas Giaginis, Alexandra P. Margeli, Stamatios E Theocharis · 2007 · Expert Opinion on Investigational Drugs
- Neuroprotective Properties of a Novel Non-Thiazoledinedione Partial PPAR-γAgonist against MPTPChristine R. Swanson, Eric Yiwei Du, Delinda A. Johnson, Jeffrey Allan Johnson, Marina Elena Emborg · 2013 · PPAR Research
- PPAR-γ signaling pathway in placental development and function: A potential therapeutic target in the treatment of gestational diseasesCostas Giaginis, Evangelia Spanopoulou, Stamatios E Theocharis · 2008 · Expert Opinion on Therapeutic Targets
- Novel Insulin Sensitizer Modulates Nutrient Sensing Pathways and Maintains β-Cell Phenotype in Human IsletsNidhi Rohatgi, Haytham Aly, Connie A. Marshall, William G. McDonald, Rolf F. Kletzien, Jerry R. Colca, Michael L. McDaniel · 2013 · PLoS ONE
- Peroxisome Proliferator‐Activated Receptor‐ γ Ligands: Potential Pharmacological Agents for Targeting the Angiogenesis Signaling Cascade in CancerCostas Giaginis, Anna Tsantili‐Kakoulidou, Stamatios E Theocharis · 2008 · PPAR Research
- Insulin Resistance Is Not Conserved in Myotubes Established from Women with PCOSMette Brandt Eriksen, Ann Dorte Pørneki, Vibe Skov, Jorge Sans Burns, Henning Beck‐Nielsen, Dorte Glintborg, Michael Gaster · 2010 · PLoS ONE
- Adipocyte mitochondrial genes and the forkhead factor FOXC2 are decreased in type 2 diabetes patients and normalized in response to rosiglitazoneJoakim Håkansson, Björn Eliasson, Ulf Smith, Sven Enerbäck · 2011 · Diabetology & Metabolic Syndrome
- PPARγ Agonists Attenuate Trigeminal Neuropathic PainDanielle N. Lyons, Liping Zhang, Robert J. Danaher, Craig S. Miller, Karin N. Westlund · 2017 · Clinical Journal of Pain
- Glitazonas e síndrome metabólica: mecanismos de ação, fisiopatologia e indicações terapêuticasMarília Brito Gomes · 2006 · Arquivos Brasileiros de Endocrinologia & Metabologia
- Involvement of NMDA receptors in the beneficial effects of pioglitazone on scopolamine-induced memory impairment in miceMina Almasi‐Nasrabadi, Mehrak Javadi Paydar, Shirin Mahdavian, Rosa Babaei, Maedeh Sharifian, Abbas Norouzi, Ahmad Reza Dehpour · 2012 · Behavioural Brain Research
- Investigation of the lipophilic behaviour of some thiazolidinedionesCostas Giaginis, Stamatios E Theocharis, Anna Tsantili‐Kakoulidou · 2007 · Journal of Chromatography B
- Determination of liver specific toxicities in rat hepatocytes by high content imaging during 2-week multiple treatmentDavide Germano, Marianne Uteng, François Pognan, Salah‐Dine Chibout, Armin Wolf · 2014 · Toxicology in Vitro
- Differential effects of PPARγ agonists on the metabolic properties of gliomas and astrocytesAlessandra Spagnolo, Erica N. Grant, Roberta P. Glick, Terry Lichtor, Douglas L. Feinstein · 2007 · Neuroscience Letters
- PPARγin Bacterial Infections: A Friend or Foe?Aravind T. Reddy, Sowmya P. Lakshmi, Raju C. Reddy · 2016 · PPAR Research
- Rosiglitazone in the thawing medium improves mitochondrial function in stallion spermatozoa through regulating Akt phosphorylation and reduction of caspase 3Jose Manuel Ortiz-Rodriguez, C Balao da Silva, Javier Masot, Eloy Redondo, Antonio Gazquez, Jose Antonio Tapia, Cruz Gil, Cristina Ortega‐Ferrusola, Fernando Juan Peña · 2019 · PLoS ONE
- Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer’s disease and decreases it in wild-type miceElena Galea, Douglas L. Feinstein, Pierre M. Lacombe · 2006 · Diabetologia
- PPARγ Inhibitors as Novel Tubulin‐Targeting AgentsKatherine L. Schaefer · 2008 · PPAR Research
- Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to ChemopreventionDanny Orabi, Nathan A. Berger, Jonathan Mark Brown · 2021 · Cancers
- PTB-Associated Splicing Factor (PSF) Is a PPARγ-Binding Protein and Growth Regulator of Colon Cancer CellsTamotsu Tsukahara, Hisao Haniu, Yoshikazu Matsuda · 2013 · PLoS ONE
- Nurr1 and PPARγ protect PC12 cells against MPP+ toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairmentMohammad Jodeiri Farshbaf, Mahboobeh Forouzanfar, Kamran Ghaedi, Abbas Kiani‐Esfahani, Maryam Peymani, Alireza Shoaraye Nejati, Tayebeh Izadi, Khadijeh Karbalaie, Maryam Noorbakhshnia, Soheila Rahgozar et al. · 2016 · Molecular and Cellular Biochemistry
- Troglitazone inhibits cell proliferation by attenuation of epidermal growth factor receptor signaling independent of peroxisome proliferator-activated receptor γXiaoqi Li, Xuanming Yang, Youli Xu, Xuejun Jiang, Xin Li, Fajun Nan, Hong Tang · 2009 · Cell Research
- A novel binding assay identifies high affinity ligands to the rosiglitazone binding site of mitoNEETWerner J. Geldenhuys, Max O. Funk, Prabha S. Awale, Li Lin, Richard T. Carroll · 2011 · Bioorganic & Medicinal Chemistry Letters
- Rosiglitazone prevents diabetes by increasing beta‐cell mass in an animal model of type 2 diabetes characterized by reduced beta‐cell mass at birthAlison C. Holloway, Jim Petrik, Jennifer E. Bruin, Hertzel C. Gerstein · 2007 · Diabetes Obesity and Metabolism
- PPARγ-Independent Side Effects of Thiazolidinediones on Mitochondrial Redox State in Rat Isolated HeartsMatthias L. Riess, Reem Elorbany, Dorothée Weihrauch, David F. Stowe, Amadou K.S. Camara · 2020 · Cells
- Telmisartan modulates mitochondrial function in vascular smooth muscle cellsKiyo Takeuchi, Koichi I. Yamamoto, Mitsuru Ohishi, Hikari Takeshita, Kazuhiro Hongyo, Tatsuo Kawai, Masao Takeda, Kei Kamide, Theodore W. Kurtz, Hiromi Rakugi · 2012 · Hypertension Research
- Assessment of genotoxicity in rats treated with the antidiabetic agent, pioglitazoneAbdülkerim Bedir, Yüksel Aliyazıcıoğlu, Birşen Bilgici, Zafer Yurdakul, Mehmet Uysal, Duygu Erol Suvaci, Ali Okuyucu, Hakkı Kahraman, Murat Hökelek, Muhlise Alvur · 2008 · Environmental and Molecular Mutagenesis
- 18α‐glycyrrhetinic acid extracted from G lycyrrhiza radix inhibits proliferation and promotes apoptosis of the hepatic stellate cell lineLei Zong, Ying Qu, Ming Xu, Yu Wei Dong, Lungen Lu · 2013 · Journal of Digestive Diseases
- Metformin and glitazones: does similarity in biomolecular mechanism originate from tautomerism in these drugs?Sandeep Sundriyal, Smriti Khanna, Rikta Saha, Prasad V. Bharatam · 2007 · Journal of Physical Organic Chemistry
- Does Pioglitazone Lead to Neutrophil Extracellular Traps Formation in Chronic Granulomatous Disease Patients?Gouri Hule, Umair Ahmed Bargir, Manasi Kulkarni, Priyanka Madhav Kambli, Prasad D. Taur, Mukesh Manharlal Desai, Manisha Rajan Madkaikar · 2019 · Frontiers in Immunology
- Efecto hipoglicemiante coadyuvante del extracto etanólico de hojas de Annona muricata L (guanábana), en pacientes con diabetes tipo 2 bajo tratamiento de glibenclamidaJorge L. Arroyo, Jaime Martínez, Gerardo Ronceros, Robert Palomino, Aníbal Villarreal, Pablo E. Bonilla, Christian Palomino, Mariano Gastón Quino Florentini · 2012 · Anales de la Facultad de Medicina
- Benzylidene thiazolidinediones: Synthesis, in vitro investigations of antiproliferative mechanisms and in vivo efficacy determination in combination with ImatinibHardik Joshi, Vijay Patil, Kalpana N. Tilekar, Neha Upadhyay, Vikram Gota, C. S. Ramaa · 2020 · Bioorganic & Medicinal Chemistry Letters
- A consideration of PPAR-γ ligands with respect to lipophilicity: current trends and perspectivesCostas Giaginis, Stamatios E Theocharis, Anna Tsantili‐Kakoulidou · 2007 · Expert Opinion on Investigational Drugs
- In search of the neuroprotective mechanism of thiazolidinediones in Parkinson's diseaseDirk Andreas Ridder, Markus Schwaninger · 2012 · Experimental Neurology
- Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target?Jérôme Morel, Mervyn Singer · 2014 · Intensive Care Medicine Experimental
- The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphismPatrick A. Vigueira, Kyle S. McCommis, Wesley T. Hodges, George G. Schweitzer, Serena L. Cole, Lalita Oonthonpan, Eric B. Taylor, William G. McDonald, Rolf F. Kletzien, Jerry R. Colca et al. · 2017 · Experimental Physiology
- Lobeglitazone, A Peroxisome Proliferator-Activated Receptor-Gamma Agonist, Inhibits Papillary Thyroid Cancer Cell Migration and Invasion by Suppressing p38 MAPK Signaling PathwayJun-Qing Jin, Jeong‐Sun Han, Jeonghoon Ha, Han-Sang Baek, Dong‐Jun Lim · 2021 · Endocrinology and Metabolism
- Rosiglitazone promotes cardiac hypertrophy and alters chromatin remodeling in isolated cardiomyocytesLama Fawaz Pharaon, Naglaa F. El-Orabi, Muhammad Kunhi, Nadya Al‐Yacoub, Salma Mahmoud Awad, Coralie I Poizat · 2017 · Toxicology Letters
- High endoplasmic reticulum activity renders multiple myeloma cells hypersensitive to mitochondrial inhibitorsMetin Kurtoğlu, Katherine B. Philips, Huaping Liu, Lawrence Boise, Théodore J. Lampidis · 2009 · Cancer Chemotherapy and Pharmacology
- Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: In vivo and ex vivo studiesJanaína A Couto, Karina Lidianne Alcântara Saraiva, Cleiton Diniz Barros, Daniel Pedro Udrisar, Christina Alves Peixoto, Juliany Silveira Braglia César Vieira, Maria do Carmo Alves de Lima, Suely Lins Galdino, Ivan da Rocha Pitta, Maria Inês Wanderley · 2010 · Reproductive Biology and Endocrinology
- Therapeutic Potential of PPARγActivation in StrokeRaghu Vemuganti · 2008 · PPAR Research
- Modulation of the Nitrergic Pathway via Activation of PPAR-γ Contributes to the Neuroprotective Effect of Pioglitazone Against Streptozotocin-Induced Memory DysfunctionAtish Kumar Prakash, Anil Kumar, Long Chiau Ming, Vasudevan Mani, Abu Bakar Abdul Majeed · 2015 · Journal of Molecular Neuroscience
- Hyper-Inflammation and Skin Destruction Mediated by Rosiglitazone Activation of Macrophages in IL-6 DeficiencyLopa M. Das, Julie R. Rosenjack, Liemin Au, Pia S. Galle, Morten Bagge Hansen, Martha K. Cathcart, Thomas S. McCormick, Kevin D. Cooper, Roy L. Silverstein, Kurt Q. Lu · 2014 · Journal of Investigative Dermatology
- Harnessing peroxisome proliferator-activated receptor γ agonists to induce Heme Oxygenase-1: a promising approach for pulmonary inflammatory disordersI‐Ta Lee, Chien-Chung Yang, Chuen‐Mao Yang · 2024 · Cell Communication and Signaling
- Altering Mitochondrial Dysfunction as an Approach to Treating Alzheimer’s DiseaseJerry R. Colca, Douglas L. Feinstein · 2012 · Advances in pharmacology
- NL-1 Promotes PINK1-Parkin-Mediated Mitophagy Through MitoNEET Inhibition in Subarachnoid HemorrhageTongyu Zhang, Minghai Zhang · 2023 · Neurochemical Research